Global Clinical Trial Supply And Logistics For Pharmaceutical Market Size To Exceed USD 12.48 Billion By 2035 | CAGR Of 8.87%
Category: HealthcareGlobal Clinical Trial Supply And Logistics For Pharmaceutical Market Size To Exceed USD 12.48 Billion By 2035
According to a research report published by Spherical Insights & Consulting, The Global Clinical Trial Supply and Logistics for Pharmaceutical Market Size is Expected To Grow from USD 4.90 Billion in 2024 to USD 12.48 Billion by 2035, at a CAGR of 8.87% during the forecast period 2025-2035.
Get more details on this report -
Browse key industry insights spread across 201 pages with 119 Market data tables and figures & charts from the report on the "Global Clinical Trial Supply and Logistics for Pharmaceutical Market Size, Share, and COVID-19 Impact Analysis, By Clinical Trial Phase (Phase I, Phase II, Phase III, and Phase IV), By Product Type (Biologics, Synthetic Pharmaceuticals, Vaccines, and Combination Products), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035. "Get Detailed Report Description Here:https://www.sphericalinsights.com/reports/clinical-trial-supply-and-logistics-for-pharmaceutical-market
Clinical Trial Supply and Logistics Market Size is the end-to-end handling of all supplies and services required to carry out a clinical trial, such as investigational medications, comparator supplies, ancillary kits, packaging, labeling, storage, temperaturemcontrolled transportation, import export compliance, site delivery, return or destruction of unused materials, and related regulatory documentation, to guarantee quality, safety, and trial integrity. The frequency of chronic diseases, aging populations, and increased healthcare costs are all contributing to the rapid growth of the pharmaceutical and healthcare industries. Although there are obstacles such as high R&D expenses, stringent regulations, and pricing pressures, advancements in digital health, gene therapy, and precision medicine are improving results. Emerging markets with growing healthcare infrastructure present growth prospects, and the sector is changing due to major developments, including telehealth, AI driven personalized medicine, and sustainable pharmaceutical solutions. However, the clinical trial supply and logistics for pharmaceuticals’ high operational costs, and especially for cold chain logistics, are likely going to restrict market expansion.
The phase III segment dominated the market in 2024 and is projected to grow at a substantial CAGR of 43.64% during the forecast period.
Based on the clinical trial phase, the clinical trial supply and logistics for pharmaceutical market are divided into phase I, phase II, phase III, and phase IV. Among these, the phase III segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. The segment's development is stimulated by the fact that they are large scale, pivotal trials that involve numerous patients in numerous locations and nations, necessitating sophisticated comparator procurement, substantial volumes of investigational product, strict regulatory compliance, and enormous logistics.
The biologics segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR of 7.5% during the forecast period.
Based on the product type, the clinical trial supply and logistics for pharmaceutical market are divided into biologics, synthetic pharmaceuticals, vaccines, and combination products. Among these, the biologics segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The segment's increase is prompted by the need for advanced supply and logistics services, which is fueled by their requirements for ultra-low temperature transportation, specialized packaging, strict cold chain storage, and real time monitoring.
North America is expected to hold the majority share of the global clinical trial supply and logistics for pharmaceutical market during the forecast period.
North America is expected to hold the majority share with 38.33% of the global clinical trial supply and logistics for pharmaceutical market during the forecast period. The clinical trial supply and logistics for the pharmaceutical market are encouraged by its extensive healthcare infrastructure, significant R&D spending, sophisticated regulatory environment, large pharma presence, and adoption of technologies like decentralized trials, digital supply chains, and cold chains.
Get more details on this report -
Asia Pacific is anticipated to grow at the fastest pace with 8.5% in the global clinical trial supply and logistics for pharmaceutical market during the forecast period. The clinical trial supply and logistics for pharmaceutical market in the Asia Pacific are bolstered by the growing demand for cold chain solutions, the expansion of pharmaceutical industries in China, India, and other countries, the rise in biopharma investment, regulatory changes, and the development of clinical research centers in large cities.
Major vendors in the global clinical trial supply and logistics for pharmaceutical market are Thermo Fisher Scientific, Catalent Pharma Solutions, Marken, UPS Healthcare, PAREXEL, Almac Group, WuXi AppTec, Lonza, Nagel, World Courier, Biocair, DHL Life Sciences, DB Schenker, Celerion, World Logistics Cargo, and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
In November 2024, DHL introduced IoT-enabled tracking solutions, monitoring over 50,000 global clinical shipments to ensure precise temperature control and location tracking.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the clinical trial supply and logistics for pharmaceutical market based on the below-mentioned segments:
Global Clinical Trial Supply and Logistics for Pharmaceutical Market, By Clinical Trial Phase
- Phase I
- Phase II
- Phase III
- Phase IV
Global Clinical Trial Supply and Logistics for Pharmaceutical Market, By Product Type
- Biologics
- Synthetic Pharmaceuticals
- Vaccines
- Combination Products
Global Clinical Trial Supply and Logistics for Pharmaceutical Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?